These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 22277173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I, Mazurek J, Khullar P, Saeed W, Vittorio T, Zolty R.
    Congest Heart Fail; 2012; 18(3):158-64. PubMed ID: 22497779
    [Abstract] [Full Text] [Related]

  • 3. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S, Clarke K, Srinivasan V, Gradman A.
    QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
    [Abstract] [Full Text] [Related]

  • 4. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 5. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 6. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW, Singh A.
    Am J Cardiol; 2006 Jul 15; 98(2):226-9. PubMed ID: 16828598
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS.
    Int J Cardiol; 2008 May 23; 126(2):234-9. PubMed ID: 17482692
    [Abstract] [Full Text] [Related]

  • 8. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL, Peng JT, Okamoto MP, Heywood JT.
    Ann Pharmacother; 2007 Apr 23; 41(4):556-61. PubMed ID: 17389662
    [Abstract] [Full Text] [Related]

  • 9. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.
    Circulation; 2014 Sep 16; 130(12):958-65. PubMed ID: 25074507
    [Abstract] [Full Text] [Related]

  • 10. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD, Chatterjee K, De Marco T.
    J Card Fail; 2005 Aug 16; 11(6):425-31. PubMed ID: 16105633
    [Abstract] [Full Text] [Related]

  • 11. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.
    J Cardiovasc Pharmacol Ther; 2007 Sep 16; 12(3):232-6. PubMed ID: 17875951
    [Abstract] [Full Text] [Related]

  • 12. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.
    N Engl J Med; 2011 Jul 07; 365(1):32-43. PubMed ID: 21732835
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R, FUSION II Investigators.
    Circ Heart Fail; 2008 May 07; 1(1):9-16. PubMed ID: 19808265
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
    Ng TM, Ackerbauer KA, Hyderi AF, Hshieh S, Elkayam U.
    J Cardiovasc Pharmacol Ther; 2012 Mar 07; 17(1):79-85. PubMed ID: 21536855
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
    Ejaz AA, Martin TD, Johnson RJ, Winterstein AG, Klodell CT, Hess PJ, Ali AK, Whidden EM, Staples NL, Alexander JA, House-Fancher MA, Beaver TM.
    J Thorac Cardiovasc Surg; 2009 Oct 07; 138(4):959-64. PubMed ID: 19660420
    [Abstract] [Full Text] [Related]

  • 16. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG, Redfield MM, Burnett JC, Chen HH.
    J Am Coll Cardiol; 2006 Jun 06; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA, Wahlstrom HD.
    Pharmacotherapy; 2004 Nov 06; 24(11):1634-7. PubMed ID: 15537565
    [Abstract] [Full Text] [Related]

  • 18. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.
    Mentzer RM, Oz MC, Sladen RN, Graeve AH, Hebeler RF, Luber JM, Smedira NG, NAPA Investigators.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):716-26. PubMed ID: 17291938
    [Abstract] [Full Text] [Related]

  • 19. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH, Nazeer S, Pepe P, Estes B, Gorman A, Yancy CW.
    Ann Emerg Med; 2008 May 13; 51(5):571-8. PubMed ID: 18304693
    [Abstract] [Full Text] [Related]

  • 20. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 13; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.